[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368811-105":59,"doc-detail-368811-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","precision-risk-stratification-of-primary-gastric-cancer-after-eradication-of-h-pylori-by-a-dna-methylation-marker-a-multicentre-prospective-study","Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker - a multicentre prospective study","","Precision cancer risk stratification for gastric cancer is increasingly needed for people remaining healthy after Helicobacter pylori eradication. Epimutation burden in non-malignant tissues has been linked to cancer risk, but clinical usefulness requires prospective confirmation. In a multicentre prospective study, RIMS1 DNA methylation in gastric biopsies stratified incidence across methylation quartiles, yielding hazard ratios up to 7.7 and a methylation cut-off defining a super-high-risk group. Super-high-risk individuals required more frequent screening.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/precision-risk-stratification-of-primary-gastric-cancer-after-eradication-of-h-pylori-by-a-dna-methylation-marker-a-multicentre-prospective-study/368811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/precision-risk-stratification-of-primary-gastric-cancer-after-eradication-of-h-pylori-by-a-dna-methylation-marker-a-multicentre-prospective-study/368811.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of this study?","Question",{"text":113,"@type":114},"To confirm the clinical usefulness of a DNA methylation marker for epimutation burden and to identify a cut-off methylation level for a super-high-risk population after H. pylori eradication.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants selected and followed?",{"text":118,"@type":114},"Healthy people after H. pylori eradication with open-type atrophy were prospectively recruited, and gastric antrum/body biopsies were collected to measure RIMS1 methylation, with endoscopic follow-up for cancer incidence.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the RIMS1 methylation quartiles show about cancer risk?",{"text":122,"@type":114},"The highest quartile of RIMS1 methylation had a much higher primary gastric cancer incidence rate than the lowest quartile; Cox regression showed elevated hazard ratios after univariate and age/sex adjustment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368811,1790726738,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","GI cancer  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1136/gutjnl-2025-335039](10.1136/gutjnl-2025-335039)) .  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Toshikazu Ushijima; [tushijima142@hoshi.ac.jp](tushijima142@hoshi.ac.jp)  \nReceived 7 February 2025 Accepted 14 March 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nTo cite: Yamada H, Abe S, Charvat H, et al. Gut Epub ahead of print: [please include Day Month Year] . doi:10.1136/ gutjnl-2025-335039  \nOriginal research  \nPrecision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study  \nHarumi Yamada  , 1,2,3 Seiichiro Abe  ,4 Hadrien Charvat,5,6 Takayuki Ando,7 Masahiro Maeda,2,3 Kazunari Murakami,8 Shiro Oka  ,9 Takao Maekita, 10 Mitsushige Sugimoto, 11,12 Takahisa Furuta, 13 Mitsuru Kaise, 14 Nobutake Yamamichi, 15 Hiroyuki Takamaru  ,4 Akiko Sasaki, 16 Ichiro Oda  ,4 Sohachi Nanjo,7 Nobuhiro Suzuki, 17 Toshiro Sugiyama,7,18 Masaaki Kodama,8,19 Kazuhiro Mizukami,8 Masanori Ito,9 Takahiro Kotachi,9 Taichi Shimazu  ,20 Seiichiro Yamamoto,21 Toshikazu Ushijima  1,3  \nABSTRACT  \nBackground Precision cancer risk stratification for gastric cancer is urgently needed for the growing number of healthy people after Helicobacter pylori eradication. The epimutation burden in non-malignant tissues has been associated with cancer risk in multiple crosssectional studies.  \nObjective To confirm the clinical usefulness of a DNA methylation marker for epimutation burden, and to identify a cut-off methylation level for a super-high-risk population.  \nDesign Healthy people after H. pylori eradication with open-type atrophy were prospectively recruited.  \nDNA methylation levels of a marker gene, RIMS1, were measured in biopsy specimens from gastric antrum and body. The primary endpoint was the incidence rate of gastric cancer in quartiles of the methylation levels. Results 1624 participants had at least one endoscopic follow-up with a median follow-up of 4.05 years, anda primary gastric cancer developed in 27 participants. The highest quartile of RIMS1 methylation levels had a higher incidence rate (972.8 per 100 000 person-years) than the lowest quartile (127 . 1) . Cox regression analysis revealed a univariate HR of 7.7 (95% CI 1.8–33. 7) and an age-and sex-adjusted HR of 5.7 (95% CI 1.3–25. 5) . As a secondary objective, a cut-off methylation level of 25. 7%(95% CI 1.7–7. 7) was obtained to identify a population with a super-high risk based on the number needed to screen of 1000.  \nConclusion A DNA methylation marker can risk-stratify healthy people after H. pylori eradication even though all of them have clinically high risk. Individuals with super-high risk will need more frequent gastric cancer screening than currently recommended.  \nTrial registration number UMIN-CTR000016894 .  \nINTRODUCTION  \nPrecision risk stratification for gastric cancer, the fifth most common cancer (968 000 cases) and the fifth most common cause of cancer death (660 000 deaths) in 2022 worldwide,1 is important.  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Risk stratification of primary gastric cancer in healthy people after Helicobacter pylori eradication is urgently needed since the number of such people is rapidly increasing and gastric cancer can develop in 0.5%–1.2% of them.\u003Cbr>⇒ Accumulation levels of epimutations (aberrant DNA methylation), namely epimutation burden, in non-malignant gastric tissues can be measured by a DNA methylation marker, and are correlated with cancer risk by multiple cross-sectional studies.\u003Cbr>⇒ However, the utility of a DNA methylation marker for risk prediction of primary cancer in healthy people after H. pylori eradication has not ye","cbCaidAJNwhC8UE8","https://ap.wps.com/l/cbCaidAJNwhC8UE8","pdf",1160282,"English","# Abstract\n# Introduction\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Background and rationale\n# Study design and outcomes","[{\"question\":\"What is the purpose of this study?\",\"answer\":\"To confirm the clinical usefulness of a DNA methylation marker for epimutation burden and to identify a cut-off methylation level for a super-high-risk population after H. pylori eradication.\"},{\"question\":\"How were participants selected and followed?\",\"answer\":\"Healthy people after H. pylori eradication with open-type atrophy were prospectively recruited, and gastric antrum/body biopsies were collected to measure RIMS1 methylation, with endoscopic follow-up for cancer incidence.\"},{\"question\":\"What did the RIMS1 methylation quartiles show about cancer risk?\",\"answer\":\"The highest quartile of RIMS1 methylation had a much higher primary gastric cancer incidence rate than the lowest quartile; Cox regression showed elevated hazard ratios after univariate and age/sex adjustment.\"}]","Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker - a multicentre prospective study | PDF",1790178729,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47d1cb7f8b784a4d6fc2632ebe52e4e5.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5810e620e93194b32d96a70cf7f1f2ef.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77e29ceb78bbf2df4eeec2194aba9769.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97ded9db07e540941433027bb5f1de5c.webp",980,1306]